Engineering an Antibiotic to Fight Cancer: Optimization of the Novobiocin Scaffold to Produce Anti-proliferative Agents
- 9 May 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 54 (11), 3839-3853
- https://doi.org/10.1021/jm200148p
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Cytotoxic sugar analogues of an optimized novobiocin scaffoldMedChemComm, 2010
- Synthesis and Evaluation of Noviose Replacements on Novobiocin That Manifest Antiproliferative ActivityACS Medicinal Chemistry Letters, 2010
- KU135, a Novel Novobiocin-Derived C-Terminal Inhibitor of the 90-kDa Heat Shock Protein, Exerts Potent Antiproliferative Effects in Human Leukemic CellsMolecular Pharmacology, 2009
- To Fold or Not to Fold: Modulation and Consequences of Hsp90 InhibitionFuture Medicinal Chemistry, 2009
- The Design, Synthesis, and Evaluation of Coumarin Ring Derivatives of the Novobiocin Scaffold that Exhibit Antiproliferative ActivityThe Journal of Organic Chemistry, 2008
- Hsp90 Inhibitors Identified from a Library of Novobiocin AnaloguesJournal of the American Chemical Society, 2005
- Synthesis of Mono- and Dihydroxylated Furanoses, Pyranoses, and an Oxepanose for the Preparation of Natural Product Analogue LibrariesThe Journal of Organic Chemistry, 2005
- Synthesis of (−)-Noviose from 2,3-O-Isopropylidene-d-erythronolactolThe Journal of Organic Chemistry, 2004
- How Important Is theN-3 Sugar Moiety in the Tight-Binding Interaction of Coformycin with Adenosine Deaminase?Biochemical and Biophysical Research Communications, 1997
- The 43-kilodalton N-terminal fragment of the DNA gyrase B protein hydrolyzes ATP and binds coumarin drugsBiochemistry, 1993